Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Biogen Idec buys Convergence

January 14, 2015 Sales and Marketing BG00010, Biogen IDEC, CNV1014802, Colombia University Medical Center, Convergence, Neublastin

Biogen Idec is to acquire independent UK-based Convergence Pharmaceuticals to strengthen its pipeline of drugs for pain management in a …
News

BMS Opdivo trial scores early goal

January 14, 2015 Research and Development, Sales and Marketing BMS, Merck, cancer nsclc, keytruda, nivolumab, opdivo

A late-stage trial of Bristol-Myers Squibb’s lung cancer drug Opdivo has been stopped early after showing promising results – but …
News

Immunocore names chief executive

January 14, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eliot Forster, immunocore

Oxford-based biotec Immunocore has announced the appointment of Dr Eliot Forster as its chief executive with immediate effect. Forster takes …
Appointment

Lilly, BMS and Merck unite for cancer trials

January 13, 2015 Research and Development, Sales and Marketing BMS, Cancer, Galunisertib, Merck, NSCLC, keytruda, lilly, oncology, opdivo

Lilly will test some of its compounds in combination with rival cancer drugs from Bristol-Myers Squibb and Merck, the companies …
News

Roche teams up to tackle antibiotics resistance

January 13, 2015 Research and Development, Sales and Marketing Antibiotics, Fedora, Meiji, OP0595, Roche, Teixobactin

Roche is to collaborate with Japan-based pharma firm Meiji and Canadian Fedora – two companies specialising in the production of …
News

New UCB chief starts and expands team

January 13, 2015 Sales and Marketing Cimzia, Jean-Christophe Tellier, Neupro, UCB, roch deliveux, vimpat

New UCB chief executive Jean-Christophe Tellier who succeeded Roch Doliveux this year has also welcomed three new members to the …
News

Oryzon Genomics names CFO and executive VP

January 13, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gregory Weaver, Oryzon genomics

Spanish clinical stage biopharma firm Oryzon Genomics has appointed Gregory Weaver as its executive vice president and chief financial officer. …
Appointment

Another NICE no for Dendreon cancer drug

January 13, 2015 Sales and Marketing Cancer, Dendreon, FDA, NHS, NICE, Provenge, sipuleucel-T

Dendreon has seen its prostate cancer treatment for people whose disease has spread and who are not yet suitable for …
News

NHS drops 25 treatments from Cancer Drugs Fund

January 12, 2015 Sales and Marketing Afinitor, CDF, Cancer, Cancer Drugs Fund, Eisa, Halaven, Heribulin, Jevtana, NHS, Sanofi, Zaltrap, aflibercept, cabazitaxel, everolimus

Twenty-five cancer treatments will be removed from the Cancer Drugs Fund list, NHS England has announced. Having concluded its review …
News

AstraZeneca drops CDF application

January 12, 2015 Sales and Marketing AstraZeneca, CDF, Cancer, NHS, NICE, lynparza, olaparib

AstraZeneca has withdrawn its application for its drug Lynparza to be on the Cancer Drugs Fund (CDF), citing concerns with …
News

Novartis enters digital tech collaboration

January 12, 2015 Sales and Marketing Novartis, clinical trials, digital, mhealth, qualcomm, ventures

Novartis has entered an agreement with the US investment company Qualcomm Ventures to create a joint firm to support the …
News

Shire buys rare-disease firm NPS Pharma

January 12, 2015 Sales and Marketing AbbVie, Shire, gattex, natpara, nps, nps pharma

Shire is to acquire rare diseases firm NPS Pharma to enhance its profile following the collapse of its deal with …
News

Roche stakes $1 billion in cancer gene research firm

January 12, 2015 Research and Development, Sales and Marketing Cancer, Foundation Medicine, Genentech, Roche, genomics, jp morgan

Roche has announced a huge billion-dollar investment in the cancer genomics research firm Foundation Medicine. Timed with the beginning of …
News

Daiichi-Sankyo pays $39m to settle allegations

January 12, 2015 Sales and Marketing Azor, Benicar, Daiichi Sankyo, Daiichi-Sankyo, Tribenzor, Welchol, kickbacks, us justice

Daiichi-Sankyo will pay the US government and state Medicaid programmes $39 million to resolve claims that it violated the False …
News

FDA approvals: 1996 versus 2014

January 12, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, John LaMattina, LaMattina, NDA, US, appovals, drugs

As highlighted in a number of recent stories, 2014 was a banner year for the biopharmaceutical industry with 41 new …
Feature
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026